Skip to content

Drug interactions

Irinotecan + Ticagrelor

Severity: Minor

Irinotecan and Ticagrelor: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ticagrelor is a weak CYP3A4 inhibitor and could modestly raise irinotecan exposure. The clinical effect is probably small, but irinotecan toxicity such as neutropenia and diarrhoea would be the concern. Thrombocytopenia from chemotherapy also raises bleeding risk with ticagrelor.

What this interaction means in plain words

Irinotecan and Ticagrelor have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Irinotecan belongs to Oncology; Ticagrelor belongs to Cardiovascular.

Evidence level: Low

Why it happens

Weak CYP3A4 inhibition by ticagrelor may reduce irinotecan clearance.

What to do

No routine dose change is required. Monitor for diarrhoea, neutropenia and bleeding, particularly if platelet counts fall.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Irinotecan and Ticagrelor, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Irinotecan with Ticagrelor?

MediHelp rates the interaction as minor. Irinotecan and Ticagrelor have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Ticagrelor is a weak CYP3A4 inhibitor and could modestly raise irinotecan exposure. The clinical effect is probably small, but irinotecan toxicity such as neutropenia and diarrhoea would be the concern. Thrombocytopenia from chemotherapy also raises bleeding risk with ticagrelor.

How serious is the interaction between Irinotecan and Ticagrelor?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine dose change is required. Monitor for diarrhoea, neutropenia and bleeding, particularly if platelet counts fall.

What other medicines interact with Irinotecan?

MediHelp also lists interactions of Irinotecan with, for example, Clozapine, Sacituzumab govitecan, Adenovirus types 4 and 7 live. The full list is on the Irinotecan page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in